Snap-8
Dosage Protocol
Snap-8 (acetyl octapeptide-3) is a synthetic octapeptide designed to mimic the N-terminal end of SNAP-25 — a SNARE complex protein essential for acetylcholine vesicle fusion at neuromuscular junctions. By competing with SNAP-25, it moderates acetylcholine release and reduces muscle contraction at the injection/application site, producing a topical Botox-like effect on expression lines.
What is Snap-8?
Snap-8 was developed as a cosmetic alternative to botulinum toxin (Botox) for reducing expression lines — particularly crow's feet, forehead lines, and glabellar lines formed by repetitive facial muscle contractions. It works by partially inhibiting the SNARE complex mechanism that governs acetylcholine vesicle fusion at neuromuscular junctions, reducing but not eliminating muscle contraction.
Unlike Botox, Snap-8 is topically applied and produces a gradual, moderate reduction in muscle contraction rather than a complete block. It is typically incorporated into serums or creams at 5–10% concentrations. Research shows significant reduction in wrinkle depth and skin roughness with regular use, though effects are more subtle than injectable neurotoxins.
Dosing Schedule
Parameters documented in published preclinical and clinical research.
| Phase | Dose | Frequency | Duration | Notes |
|---|---|---|---|---|
| Standard topical | 5–10% in serum/cream | 1–2× daily | Ongoing | Apply to expression lines (crow's feet, forehead, glabellar). Massage in gently. |
| Concentrated serum | 10% | Evening application | Ongoing | Higher concentration for more pronounced effect. Evening allows overnight penetration. |
| Combined | 5% Snap-8 + Argireline | 2× daily | Ongoing | Combination with other SNARE inhibitors for synergistic effect on expression lines. |
| Maintenance | 5% | Once daily | Long-term | Lower frequency maintenance once desired results achieved. |
Safety & Side Effects
Academic References
-
[1]
Blanes-Mira C, et al. (2002). A small peptide blocks the SNARE complex mechanism relevant to neural exocytosis. J Neurochem. 81(4):656–63. PubMed ↗
-
[2]
Lunev IV, et al. (2020). The cosmetic use of topical peptides in skin aging. Molecules. 25(15):3540. PubMed ↗
-
[3]
Katayama K, et al. (2007). A pentapeptide from laminin B1 chain-related sequences stimulates fibronectin and collagen production by normal and lesional skin fibroblasts. Br J Dermatol. 146(4):670–9. PubMed ↗
-
[4]
Fields K, et al. (2019). Skin care perspective on cosmetic peptides. J Drugs Dermatol. 18(5):461–5. PubMed ↗